Brandinium

Trademark search for:

FRAIZERON

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2015-09-23 — Application filed
  • 2015-12-17 — Sn assigned for sect 66a subseq desig from ib
  • 2015-12-18 — Application filed
  • 2015-12-28 — Application filed
  • 2016-01-01 — Application filed
  • 2016-01-12 — Approved for pub - principal register
  • 2016-01-12 — Assigned to examiner
  • 2016-01-27 — Notice of publication
  • 2016-02-10 — Notification of possible opposition sent to ib
  • 2016-02-10 — Notice of start of opposition period created, to be sent to ib
  • 2016-02-16 — Published for opposition
  • 2016-02-26 — Notification processed by ib
  • 2016-05-03 — Registered-principal register
  • 2016-06-02 — Grant of protection created, to be sent to ib
  • 2016-06-03 — Final disposition recorded
  • 2016-06-03 — Final disposition recorded
  • 2016-11-18 — Notification processed by ib
  • 2018-07-29 — Final status recorded
  • 2019-02-16 — Death of international registration
  • 2019-02-16 — Notification of effect of cancellation of intl reg mailed

Owner Information

Novartis AG
CH
Novartis AG
CH
Novartis AG
CH

Correspondent

Novartis Pharma AG, Trademark Department
Postfach
CH-4002 Basel,
SWITZERLAND

Filing Details

Filing Date:
2015-09-23
Status Date:
2018-07-29
Category:
Pharmaceuticals
Filing Year:
2009

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.